Printer Friendly
The Free Library
22,728,043 articles and books

CryoLife admits misstatements contained in press release about FDA warning letter.

CryoLife, Inc., Atlanta, GA announced on July 5 that it had made two misstatements in a July 24 press release saying it had received a warning letter from the US Food and Drug Administration (FDA FDA
Food and Drug Administration

FDA, See Food and Drug Administration.

FDA, the abbreviation for the Food and Drug Administration.
) related to an inspection of the company's human tissue processing laboratories. (Transplant News, June 30, 2002)

The company issued the following corrections to the earlier release:

*"First, the Company confirmed that, as it had earlier noted in the Wall Street Journal, its comment to the effect that it had never received a warning letter was inaccurate, in that it had received a 1997 warning letter regarding carotid carotid /ca·rot·id/ (kah-rot´id) pertaining to the carotid artery, the principal artery of the neck.

 shunts manufactured by its Ideas for Medicine, Inc. subsidiary in Florida. The Company sold the product line of the Ideas for Medicine, Inc. subsidiary, consisting of disposable medical devices and infusion devices, in 1998.

*Second, with respect to the CDC's (Center for Disease Control and Prevention Noun 1. Center for Disease Control and Prevention - a federal agency in the Department of Health and Human Services; located in Atlanta; investigates and diagnoses and tries to control or prevent diseases (especially new and unusual diseases)
) investigation of two reported allograft allograft: see transplantation, medical.  heart valve inspections, the Company stated in its July 24, 2002 press release that it had 'received pathology data from the implanting hospitals' own laboratories that clearly demonstrated there is no infection in either valve.' Based on the pathology data it received, CryoLife believed this statement to be correct. However, in subsequent communications, a CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
 representative has informed CryoLife that based on certain additional information available to the CDC, which information CryoLife has requested but not yet been able to obtain, signs of fungal infection fungal infection, infection caused by a fungus (see Fungi), some affecting animals, others plants. Fungal Infections of Human and Animals
 were isolated on a culture of the explanted valve. Information currently available to the Company indicates that the valve was explanted approximately seven months after the valve was implanted."

Regarding the unusual corrections issued following the original release CryoLife President Steven Anderson Steven James Stuart Anderson (born December 19, 1985 in Edinburgh) is a Scottish professional footballer, currently playing for St. Johnstone. Anderson, a right back, joined the Perth club from Tayside rivals Dundee United in the summer of 2004.  said: "We are undertaking an immediate effort to obtain the reports upon which the CDC opinion is premised and fully intend to further improve our communications with hospitals, physicians, the CDC, and others in order to help insure that we receive all relevant information as soon after its release as possible."

Contact: Roy Vogeltanz - (800) 438-8285
COPYRIGHT 2002 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Publication:Transplant News
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 12, 2002
Previous Article:Gerberding named to head CDC.
Next Article:RTI introduces next generation of BioCleanse, restructures agreement with MSD.

Related Articles
CryoLife receives warning letter from FDA following inspection of tissue processing labs.
CryoLife hit with 7 lawsuits over death of Minnesota man attributed to tainted tissue.
Following a warning letter from FDA, AlloSource defused situation by acting openly with customers, press-Cycyota.
CryoLife completes most corrective actions required by FDA, signs agreement with curasan AG.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters